Mendelian genetics of human susceptibility to fungal infection

Michail S Lionakis1, Mihai G Netea2, Steven M Holland3

  • 1Fungal Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Insights

Newly identified genetic immune disorders reveal key cellular and molecular pathways for fighting fungal infections. Studying these inborn errors of immune function offers insights for developing new antifungal therapies.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Advances in genetics have led to the discovery of numerous inborn errors of immune function.
  • These genetic defects often result in increased susceptibility to fungal infections.

Purpose of the Study:

  • To enhance understanding of the cellular and molecular mechanisms underlying antifungal immune responses.
  • To identify novel molecules and signaling pathways critical for host defense against fungi.

Main Methods:

  • Characterization of single-gene defects associated with fungal disease susceptibility.
  • Analysis of patients with various fungal infections (yeasts, molds, dimorphic fungi).

Main Results:

  • Discovery of novel genetic factors influencing antifungal immunity.
  • Unmasking of critical molecular pathways in mucosal and systemic antifungal defense.

Conclusions:

  • Inborn errors of immune function provide unique insights into antifungal host defense.
  • These findings lay the groundwork for developing novel immune-based therapeutic strategies for fungal infections.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Pedigree Analysis01:35

Pedigree Analysis

Overview
78.8K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
780
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
18.9K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
94.0K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
157